Expression of concern "hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma"

Authors

DOI:

https://doi.org/10.17179/excli2026-9895

Keywords:

hsa-miR-34a-5p, temozolomide, glioblastoma, MAPK pathway

Downloads

Published

2026-11-02

How to Cite

Abdoli Shadbad, M., Baghbanzadeh, A., & Baradaran, B. (2026). Expression of concern "hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma". EXCLI Journal, 25, 1634–1635. https://doi.org/10.17179/excli2026-9895

Issue

Section

Corrigenda

Categories

Most read articles by the same author(s)